Inventor · disambiguated record
Javier López Ogalla
Also filed as: LOPEZ OGALLA JAVIER · LÓPEZ OGALLA JAVIER
3 granted patents·5 pending applications·4 citations·filing 2007–2016
57Inventor score
Technology areasA61P
Files withNOSCIRA SA3ASD THERAPEUTICS PARTNERS LLC2NEUROPHARMA SA1PALOMO NICOLAU FRANCISCO1ZELTIA S A1
Top patents by PatentIndex Score
8 records- 0161US9284296B2Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditionsPALOMO NICOLAU FRANCISCO·Filed 2011·Granted Mar 15, 2016·3 cites·18 claims
- 0257US9371299B2Thiadiazolidinediones as GSK-3 inhibitorsASD THERAPEUTICS PARTNERS LLC·Filed 2013·Granted Jun 21, 2016·1 cites·12 claims
- 0343US2011092591A1Phenyl-prenyl derivatives, of marine and synthetic origin, for the treatment of cognitive, neurodegenerative or neuronal diseases or disordersNOSCIRA SA·Filed 2009·Application pending·0 cites
- 0441US2009069430A1Dibenzene derivatives as calcium channel blockersNEUROPHARMA SA·Filed 2008·Application pending·0 cites
- 0539US2010041665A1N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disordersNOSCIRA SA·Filed 2007·Application pending·0 cites
- 0638US9469618B2Thiadiazolidinediones as GSK-3 inhibitorsASD THERAPEUTICS PARTNERS LLC·Filed 2016·Granted Oct 18, 2016·0 cites·9 claims
- 0738US2010267827A1Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disordersNOSCIRA SA·Filed 2007·Application pending·0 cites
- 0837US2011213000A1N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseasesZELTIA S A·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Javier López Ogalla files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →